Issues lobbied + lobbyists
HCR — Health Issues
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
Lobbyists: MARC SCHLOSS; DAVID CHARLES SPANGLER; JOLIE BROCHIN
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE; White House Office
PHA — Pharmacy
H.R.4958 - GRAS Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
Lobbyists: MARC SCHLOSS; DAVID CHARLES SPANGLER; JOLIE BROCHIN
Government entities lobbied: Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; White House Office
CSP — Consumer Issues/Safety/Products
- The SHOP SAFE Act - Advocacy to protect funding for the Office of the Intellectual Property Enforcement Coordinator (IPEC) and to advocate for an IPEC appointment before the end of the year.
Lobbyists: MARC SCHLOSS; DAVID CHARLES SPANGLER; JOLIE BROCHIN
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
TAX — Taxation/Internal Revenue Code
- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
Lobbyists: MARC SCHLOSS; DAVID CHARLES SPANGLER; JOLIE BROCHIN
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE; White House Office
MAN — Manufacturing
- Pharmaceutical Tariffs
Lobbyists: MARC SCHLOSS; DAVID CHARLES SPANGLER; JOLIE BROCHIN
Government entities lobbied: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; White House Office